Hsbc Holdings PLC lifted its holdings in shares of agilon health, inc. (NYSE:AGL - Free Report) by 205.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 132,952 shares of the company's stock after purchasing an additional 89,407 shares during the period. Hsbc Holdings PLC's holdings in agilon health were worth $249,000 at the end of the most recent reporting period.
Other large investors also recently added to or reduced their stakes in the company. Oak Thistle LLC bought a new stake in shares of agilon health during the fourth quarter valued at about $25,000. Ieq Capital LLC bought a new stake in shares of agilon health during the fourth quarter valued at about $26,000. Signaturefd LLC increased its position in shares of agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after buying an additional 8,467 shares during the period. Raymond James Financial Inc. bought a new stake in shares of agilon health during the fourth quarter valued at about $33,000. Finally, Cerity Partners LLC bought a new stake in shares of agilon health during the fourth quarter valued at about $34,000.
Analyst Upgrades and Downgrades
Several research analysts have recently commented on the company. Needham & Company LLC reissued a "hold" rating on shares of agilon health in a report on Friday, March 21st. Royal Bank of Canada upped their target price on agilon health from $3.00 to $3.50 and gave the stock an "outperform" rating in a research note on Wednesday, February 26th. Sanford C. Bernstein raised agilon health from a "market perform" rating to an "outperform" rating and upped their target price for the stock from $3.30 to $8.50 in a research note on Tuesday, April 8th. Robert W. Baird cut their target price on agilon health from $6.00 to $5.00 and set a "neutral" rating for the company in a research note on Tuesday, April 15th. Finally, Stifel Nicolaus upped their target price on agilon health from $2.00 to $3.00 and gave the stock a "hold" rating in a research note on Wednesday, February 26th. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $4.89.
Read Our Latest Report on agilon health
agilon health Price Performance
AGL traded up $0.08 on Monday, hitting $2.97. 4,119,398 shares of the company's stock traded hands, compared to its average volume of 4,898,444. The company's 50 day simple moving average is $4.26 and its 200-day simple moving average is $3.20. The firm has a market cap of $1.23 billion, a price-to-earnings ratio of -3.15 and a beta of 0.38. agilon health, inc. has a one year low of $1.50 and a one year high of $7.73. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.
agilon health (NYSE:AGL - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.01) by $0.04. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.50 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The company's revenue was down 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.02) EPS. As a group, research analysts anticipate that agilon health, inc. will post -0.59 EPS for the current year.
About agilon health
(
Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Stories

Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.